185 related articles for article (PubMed ID: 21042550)
1. Synthesis, characterization, and biological evaluation of poly(L-γ-glutamyl-glutamine)- paclitaxel nanoconjugate.
Van S; Das SK; Wang X; Feng Z; Jin Y; Hou Z; Chen F; Pham A; Jiang N; Howell SB; Yu L
Int J Nanomedicine; 2010 Oct; 5():825-37. PubMed ID: 21042550
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of an anticancer drug delivery system: Poly(l-γ-glutamyl-l-carbocisteine)-paclitaxel nanoconjugate.
Han L; Xiao Y; Fan M; Wang J; Yan Z; Wang Y; Yu L; Peng H; Zhu J
Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():113-119. PubMed ID: 28887953
[TBL] [Abstract][Full Text] [Related]
3. Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.
Luo Z; Yan Z; Jin K; Pang Q; Jiang T; Lu H; Liu X; Pang Z; Yu L; Jiang X
J Colloid Interface Sci; 2017 Mar; 490():783-796. PubMed ID: 27988470
[TBL] [Abstract][Full Text] [Related]
4. A Novel Gd-DTPA-conjugated Poly(L-γ-glutamyl-glutamine)-paclitaxel Polymeric Delivery System for Tumor Theranostics.
Gao L; Zhou J; Yu J; Li Q; Liu X; Sun L; Peng T; Wang J; Zhu J; Sun J; Lu W; Yu L; Yan Z; Wang Y
Sci Rep; 2017 Jun; 7(1):3799. PubMed ID: 28630436
[TBL] [Abstract][Full Text] [Related]
5. Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)-paclitaxel nanoparticles.
Yang D; Van S; Jiang X; Yu L
Int J Nanomedicine; 2011 Jan; 6():85-91. PubMed ID: 21289985
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment.
Yang D; Van S; Liu J; Wang J; Jiang X; Wang Y; Yu L
Int J Nanomedicine; 2011; 6():2557-66. PubMed ID: 22072890
[TBL] [Abstract][Full Text] [Related]
7. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts.
Wang X; Zhao G; Van S; Jiang N; Yu L; Vera D; Howell SB
Cancer Chemother Pharmacol; 2010 Feb; 65(3):515-26. PubMed ID: 19593566
[TBL] [Abstract][Full Text] [Related]
9. Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel.
Eldar-Boock A; Miller K; Sanchis J; Lupu R; Vicent MJ; Satchi-Fainaro R
Biomaterials; 2011 May; 32(15):3862-74. PubMed ID: 21376390
[TBL] [Abstract][Full Text] [Related]
10. Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.
Feng Z; Zhao G; Yu L; Gough D; Howell SB
Cancer Chemother Pharmacol; 2010 Apr; 65(5):923-30. PubMed ID: 19685054
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of tLyp-1 with polymeric paclitaxel conjugates: Enhanced intratumoral accumulation and anti-tumor efficacy.
Liu Z; Huang Z; Ci L; Lu L; Liu Z; Yan X; Yan Z; Yu L; Liu Y; Lu W
Pharmazie; 2017 Apr; 72(4):205-208. PubMed ID: 29441988
[TBL] [Abstract][Full Text] [Related]
12. Coarse-grained modeling study of nonpeptide RGD ligand density and PEG molecular weight on the conformation of poly(γ-glutamyl-glutamate) paclitaxel conjugates.
Peng LX; Das SK; Yu L; Howell SB; Gough DA
J Mol Model; 2011 Nov; 17(11):2973-87. PubMed ID: 21360176
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a clinical polymer-drug conjugate using multiscale modeling.
Peng LX; Ivetac A; Chaudhari AS; Van S; Zhao G; Yu L; Howell SB; McCammon JA; Gough DA
Biopolymers; 2010 Nov; 93(11):936-51. PubMed ID: 20564048
[TBL] [Abstract][Full Text] [Related]
14. Aggregation properties of a polymeric anticancer therapeutic: a coarse-grained modeling study.
Peng LX; Yu L; Howell SB; Gough DA
J Chem Inf Model; 2011 Dec; 51(12):3030-5. PubMed ID: 21995420
[TBL] [Abstract][Full Text] [Related]
15. Effect of molecular weight of PGG-paclitaxel conjugates on in vitro and in vivo efficacy.
Yang D; Liu X; Jiang X; Liu Y; Ying W; Wang H; Bai H; Taylor WD; Wang Y; Clamme JP; Co E; Chivukula P; Tsang KY; Jin Y; Yu L
J Control Release; 2012 Jul; 161(1):124-31. PubMed ID: 22521595
[TBL] [Abstract][Full Text] [Related]
16. Effects of solution concentration on the physicochemical properties of a polymeric anticancer therapeutic.
Peng LX; Yu L; Howell SB; Gough DA
Mol Pharm; 2012 Jan; 9(1):37-47. PubMed ID: 21988542
[TBL] [Abstract][Full Text] [Related]
17. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy.
Yang D; Van S; Shu Y; Liu X; Ge Y; Jiang X; Jin Y; Yu L
Int J Nanomedicine; 2012; 7():581-9. PubMed ID: 22334784
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma.
Pei Q; Hu X; Liu S; Li Y; Xie Z; Jing X
J Control Release; 2017 May; 254():23-33. PubMed ID: 28359677
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
